20
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Uptake, toxicity and radiation effects of the boron compounds DAAC-1 and DAC-1 in cultured human glioma cells

, , , , , , , , , & show all
Pages 103-112 | Published online: 03 Jul 2009

  • McBARENDSEN, G. W., BEUSKER, T. L. J., VERGROBSEN, A. J. and BUDKE, L., 1960, Effects of different ionizing radiations On human Cells in tissue Culture. Radiation Research, 13, 841-849.
  • BARTH, R. F., SOLOWAY, A. H. and BRUGGER, R. M., 1996, Boron neutron capture therapy of brain tumours: past history, current status and future potential. Cancer Investigation, 14, 534-550.
  • BLAKELY, E. A., NGO, F. Q. H., CURTIS, S. B. and TOBIAS, C. A., 1984, Heavy-ion radiobiology: cellular studies. Advances in Radiation Biology, 11, 295-389.
  • CODERRE, J. A., MAKAR, M. S., MICCA, P. L., NAWROCKY, M. M., LIU, H. B., JOEL, D. D., SLATKIN, D. N. and AMOLS, H. I., 1993, Derivations of relative biological effectiveness for the high-LET radiations produced during boron neutron capture irradiations of the 9L rat gliosarcoma in vitro and in vivo. International Journal of Radiation, Oncology, Biology, Physics, 27, 1121-1129.
  • FAIRCHILD, R. G. and BOND, V. P., 1985, Current status of 10Bneutron capture therapy: enhancement of tumor dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content: a theoretical evaluation. International Journal of Radiation, Oncology, Biology, Physics, 11, 831-840.
  • GABEL, D., 1994, Present status and perspectives of boron neutron Capture therapy. Radiotherapy and Oncology, 30, 199-205.
  • GEDDA, L., OLSSON, P., PONTEN, J. and CARLSSON, J., 1996, Development and in vitro studies of epidermal growth factor-dextran conjugates for boron neutron capture therapy. Bioconjugale Chemistry, 7, 584-591.
  • HARTMAN, T. and CARLSSON, J., 1994, Radiation dose heterogeneity in receptor and antigen mediated boron neutron Capture therapy. Radiotherapy and Oncology, 31, 61-75.
  • LINDSTRÖM, P., OLSSON, P., MALMQVIST, J., PETTERSSON, J., LEMMEN, P., WERNER, B., SJOBERG, S., OLIN, A. and CARLSSON, J., 1994, New carborane-based compounds for boron neutron capture therapy: binding and toxicity of ANC-1, DAC-1 and B-Et-11-OMe in cultured human glioma and mouse melanoma cells. Anti-cancer Drugs, 5, 43-52.
  • MALMQUIST, J. and SJÖBERG, S., 1994, Synthesis of 2 [-(3-aminopropyl)-1,2-dicarba-closo-dodecaborane(12)1-ylmethoxy]-1,3-pro-panediol, a hydrophilically substituted aminoalky-O-Carborane. A eta Chemica Scandinavica, 48, 886-890.
  • STENERLÖW, B., CARLSSON, J., BLOMQUIST, E. and ERIXON, K., 1994, Clonogenic cell survival and rejoining of DNA double-strand breaks: comparisons between three cell lines after photon or He ion irradiation, international Journal of Radiation Biology, 65, 631-639.
  • TILLY, N., OLSSON, P., HARTMAN, T. et al., 1996, in vitro determination of toxicity, binding, retention, subcellular distribution and biological efficacy of the boron neutron Capture agent DAC-1. Radiotherapy and Oncology, 38, 41-50.
  • WESTERMARK, B., MAGNUSSON, A. and HELDIN, C. H., 1982, Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma Cells. Journal of Neuroscience Research, 8, 491-507.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.